Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
238-243
DOI: 10.21873/cdp.10435
Received 12 December 2024 |
Revised 09 January 2025 | Accepted 13 January 2025
Corresponding author
Kazuhiko Hashimoto, Department of Orthopedic Surgery, Kindai University Hospital, Osaka‑Sayama City, Osaka 589‑8511, Japan. Tel: +81 0723660221, Fax: +81 0723660206, e-mail:
hazzhiko@med.kindai.ac.jp
Abstract
Background/Aim: This study aimed to assess the status of medical collaboration between our hospital and affiliated institutions based on referral letters for patients with osteosarcoma. Patients and Methods: A single-center retrospective analysis of osteosarcoma referrals was conducted between September 1, 2012, and March 31, 2023. Fourteen patients were included (eight males, six females; mean age=28 years, range=8-74 years) each with a pathologically confirmed diagnosis of a malignant soft-tissue tumor and available referral documentation from previous physicians. Survey parameters included type of referral hospital, geographical area, and medical department of the referral hospital, as well as imaging and blood tests conducted and the corresponding findings. Results: Patients were referred from various medical institutions: Six from general hospitals, six from clinics, one from a university hospital, and one from a clinic with beds. Most patients (n=10) were from southern Osaka. Among the referrals, 11 patients were referred to orthopedics, two to surgery, and one to pediatrics. Analysis of imaging studies showed eight patients with only radiographs; three patients with radiographs, computed tomography (CT), and magnetic resonance imaging (MRI); one patient with only CT; one patient with only MRI; and one patient with both radiographs and CT. Imaging findings included indications of suspected malignancy in 12 patients and suspected bone tumors in two. Blood tests were conducted in two patients, namely alkaline phosphatase and C-reactive protein, and alkaline phosphatase and lactate dehydrogenase, respectively. Blood tests were not performed in the remaining 12 patients. Conclusion: Referrals for patients with osteosarcoma at our facility and related facilities were well documented, ensuring informative content and adequate medical coordination.
Keywords:
Collaboration, medical coordination, osteosarcoma, patient referrals
Introduction
Referral forms are crucial for the sharing of patient information (1). Osteosarcoma is a rare type of cancer that requires referral to a specialist, with appropriate medical coordination (2,3). To our knowledge, no comprehensive studies detailing the contents of referral letters for patients with osteosarcoma have been conducted. This study aimed to analyze the referral letters received at the Orthopedic Department of our hospital for patients with osteosarcoma, and to assess the current status of medical collaboration between our hospital and affiliated institutions.
Patients and Methods
This study was a single-center retrospective analysis. We reviewed the referrals of patients with osteosarcoma that were received at our Orthopedic Department between September 1, 2012, and March 31, 2023. The inclusion criteria were patients with a pathologically confirmed diagnosis of a malignant soft-tissue tumor and available referral documentation from a previous physician. The study included 14 patients, comprising eight males and six females, with a mean age of 28 years (range=8-74 years).
The survey parameters included the type and geographical area of the referring hospital, the referring medical department, types of imaging tests conducted, whether imaging findings were reported and the corresponding details, and whether blood tests were conducted and the corresponding findings.
Results
Table I shows the details of the included patients. Patients were referred from the following medical institutions: six from general hospitals, six from clinics, one from a university hospital, and one from a clinic with beds (Figure 1A). Ten patients were from southern Osaka, three from Wakayama Prefecture, and one from Okinawa Prefecture (Figure 1B). Among the referrals, 11 patients were referred to orthopedics, two to surgery, and one to pediatrics (Figure 1C).
The imaging studies performed were as follows: eight patients underwent only radiography; three patients underwent radiography, computed tomography (CT), and magnetic resonance imaging (MRI); one patient underwent only CT; one patient underwent only MRI; and one patient underwent both radiography and CT (Figure 1D).
The interval between symptom awareness and consultation was less than 1 month for seven patients and 2 to 3 months for four patients. The remaining three patients did not specify when they first noticed their symptoms (Figure 2A).
The imaging findings included indications of suspected malignancy, such as periosteal reaction, in 12 patients and suspected bone tumor in two patients (Figure 2B). Blood tests were conducted in two patients, namely alkaline phosphatase and C-reactive protein, and alkaline phosphatase and lactate dehydrogenase, respectively. Blood tests were not performed for the remaining 12 patients (Figure 2C).
Discussion
Effective management of malignant bone and soft-tissue tumors requires adequate knowledge, specialized training, a multidisciplinary team, and extensive experience (4). To prevent improper management, current clinical practice guidelines recommend that patients with malignant bone and soft-tissue tumors be referred to specialized institutions (5,6). The annual incidence of osteosarcoma in Japan is relatively low (approximately 200 patients) (4). Therefore, non-specialists have limited exposure to patients with osteosarcoma, only encountering approximately two such patients throughout their careers (7). This limited exposure may impact the ability of clinicians to interpret symptoms and diagnostic findings related to osteosarcoma and make the appropriate referrals to specialists.
As of March 2022, only 199 (0.8%) out of 25,769 orthopedic surgeons in Japan were registered as orthopedic oncologists (4). In general, orthopedic surgeons are more mindful of tumor size than non-orthopedic surgeons, indicating that the Japanese Orthopaedic Association clinical practice guidelines on the management of soft-tissue tumors may be more commonly followed by orthopedic surgeons (4). Family physicians and pediatricians are often the first clinicians to encounter patients with osteosarcoma (8). Ideally, physicians across all specialties and departments should be familiar with the practice guidelines for managing bone and soft-tissue tumors. In this study, both orthopedic and non-orthopedic surgeons adhered to the noted referral guidelines.
In a study to analyze the prognostic impact of diagnostic delay in osteosarcoma in adults in a Mexican population at a specialized sarcoma center, the median time from the onset of osteosarcoma symptoms to diagnosis was 6 months (range=2-36 months) (9). An incorrect diagnosis can lead to inappropriate resection (10,11). A delayed diagnosis is associated with a poor prognosis (9) and can result in litigation (12). The present study revealed no such delays in referrals for our patients with osteosarcoma. Additionally, the patients included in the current study were scheduled for and underwent surgery as soon as possible after referral.
According to the 2022 Guidelines for Malignant Bone Tumors, standard radiography is recommended as the primary diagnostic tool for patients with suspected osteosarcoma (13). CT, MRI, and blood tests are considered adjunct diagnostic methods. In the present study, the initial examinations were generally of high quality.
This retrospective single-center study on osteosarcoma referrals has notable limitations, primarily its small sample size (14 patients), narrow geographical focus (mostly southern Osaka), and retrospective design. The research lacks comprehensive outcome data, comparative analysis, and detailed insights into multidisciplinary collaboration. While providing preliminary insights into referral patterns, the study’s restricted scope necessitates further large-scale, multi-institutional research to draw definitive conclusions about osteosarcoma referral practices.
In conclusion, the study of osteosarcoma referrals at our facility revealed generally well-documented practices and adequate medical coordination. However, several areas for improvement were identified, including standardizing diagnostic procedures, expanding blood testing, enhancing documentation of symptom onset, promoting a multidisciplinary approach, and addressing geographical disparities in referrals. Recommendations for practice improvement include developing a standardized referral checklist, implementing training sessions for non-specialists, establishing a fast-track referral system, creating a regional specialist network, and conducting regular audits of referral practices. These measures aim to enhance early detection, improve patient outcomes, and foster more efficient medical collaboration in osteosarcoma management.
Conflicts of Interest
The Authors declare no conflicts of interest in relation to this study.
Authors’ Contributions
This study was designed by K.H. and S.N. The data acquisition was performed by K.H. S.N., and K.G. The data were analyzed by K.H. and S.N., and the results were critically examined by all Authors. K.H. had a primary role in preparing the manuscript, which was edited by S.N. and K.G. All Authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work.
References
1
Rosemann T
,
Wensing M
,
Rueter G
&
Szecsenyi J
. Referrals from general practice to consultants in Germany: if the GP is the initiator, patients’ experiences are more positive. BMC Health Serv Res.
6
5
2006.
DOI:
10.1186/1472-6963-6-5
2
Geller DS
&
Gorlick R
. Osteosarcoma: A review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol.
8
705
- 718
2010.
3
Araki Y
,
Yamamoto N
,
Hayashi K
,
Takeuchi A
,
Miwa S
,
Igarashi K
,
Higuchi T
,
Abe K
,
Taniguchi Y
,
Yonezawa H
,
Morinaga S
,
Asano Y
,
Nojima T
&
Tsuchiya H
. Primary osteosarcoma in patients over 75 years of age: a case series and literature review. In Vivo.
36(6)
2899
- 2909
2022.
DOI:
10.21873/invivo.13031
4
Hoshi M
,
Oebisu N
,
Iwai T
,
Shimatani A
,
Ban Y
,
Takada N
,
Yao H
&
Nakamura H
. Review of the referral documents of patients with malignant soft tissue tumors. Sci Rep.
12(1)
19527
2022.
DOI:
10.1038/s41598-022-24158-w
5
Casali PG
,
Bielack S
,
Abecassis N
,
Aro HT
,
Bauer S
,
Biagini R
,
Bonvalot S
,
Boukovinas I
,
Bovee JVMG
,
Brennan B
,
Brodowicz T
,
Broto JM
,
Brugières L
,
Buonadonna A
,
De Álava E
,
Dei Tos AP
,
Del Muro XG
,
Dileo P
,
Dhooge C
,
Eriksson M
,
Fagioli F
,
Fedenko A
,
Ferraresi V
,
Ferrari A
,
Ferrari S
,
Frezza AM
,
Gaspar N
,
Gasperoni S
,
Gelderblom H
,
Gil T
,
Grignani G
,
Gronchi A
,
Haas RL
,
Hassan B
,
Hecker-Nolting S
,
Hohenberger P
,
Issels R
,
Joensuu H
,
Jones RL
,
Judson I
,
Jutte P
,
Kaal S
,
Kager L
,
Kasper B
,
Kopeckova K
,
Krákorová DA
,
Ladenstein R
,
Le Cesne A
,
Lugowska I
,
Merimsky O
,
Montemurro M
,
Morland B
,
Pantaleo MA
,
Piana R
,
Picci P
,
Piperno-Neumann S
,
Pousa AL
,
Reichardt P
,
Robinson MH
,
Rutkowski P
,
Safwat AA
,
Schöffski P
,
Sleijfer S
,
Stacchiotti S
,
Strauss SJ
,
Sundby Hall K
,
Unk M
,
Van Coevorden F
,
van der Graaf WTA
,
Whelan J
,
Wardelmann E
,
Zaikova O
,
Blay JY
&
ESMO Guidelines Committee, PaedCan and ERN EURACAN
. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol.
29(Suppl 4)
iv79
- iv95
2018.
DOI:
10.1093/annonc/mdy310
6
Nakamura T
,
Ogura K
,
Hayakawa K
,
Ikuta K
,
Nezu Y
,
Miwa S
,
Yoshida S
,
Nakai S
,
Kinoshita H
,
Kawabata Y
,
Hamada S
,
Nabeshima A
,
Outani H
,
Kobayashi H
,
Hara H
,
Tsugita M
,
Koyanagi H
,
Setsu N
,
Maekawa A
,
Daisaku A
,
Mori T
,
Oike N
,
Kubota Y
,
Tanaka T
,
Noguchi T
,
Tajima T
,
Tanaka K
&
Ozaki T
. Real-world referral pattern of unplanned excision in patients with soft-tissue sarcoma: a multicenter study conducted by the Bone and Soft-tissue Tumor Study Group of the Japan Clinical Oncology Group. In Vivo.
38(6)
2712
- 2717
2024.
DOI:
10.21873/invivo.13749
7
Fossum CC
,
Breen WG
,
Sun PY
,
Retzlaff AA
&
Okuno SH
. Assessment of familiarity with work-up guidelines for bone and soft tissue sarcoma among primary care practitioners in Minnesota. Mayo Clin Proc Innov Qual Outcomes.
4(2)
143
- 149
2020.
DOI:
10.1016/j.mayocpiqo.2019.12.002
8
Wittig JC
,
Bickels J
,
Priebat D
,
Jelinek J
,
Kellar-Graney K
,
Shmookler B
&
Malawer MM
. Osteosarcoma: A multidisciplinary approach to diagnosis and treatment. Am Fam Phys.
65(6)
1123
- 1132
2022.
9
Clara-Altamirano MA
,
García-Ortega DY
,
Álvarez-Cano A
,
Velázquez-Rodríguez S
,
Lizcano-Suárez AR
,
Rosas LC
,
Uribe-Saloma CE
,
Martínez-Said H
,
Villavicencio-Valencia V
&
Cuellar-Hubbe M
. [Delayed diagnosis of osteosarcoma in adults: A prognostic factor to be considered]. Acta Ortop Mex.
38(3)
164
- 171
2024.
DOI:
10.35366/115811
10
Dahan M
,
Anract P
,
Babinet A
,
Larousserie F
&
Biau D
. Proximal femoral osteosarcoma: Diagnostic challenges translate into delayed and inappropriate management. Orthop Traumatol Surg Res.
103(7)
1011
- 1015
2017.
DOI:
10.1016/j.otsr.2017.05.019
11
Araki Y
,
Yamamoto N
,
Hayashi K
,
Takeuchi A
,
Miwa S
,
Igarashi K
,
Takashi H
,
Kensaku A
,
Taniguchi Y
,
Yonezawa H
,
Morinaga S
,
Asano Y
&
Tsuchiya H
. Delayed initiation of treatment is associated with metastasis of soft-tissue sarcoma. Anticancer Res.
40(12)
7009
- 7015
2020.
DOI:
10.21873/anticanres.14726
12
Hwang R
,
Park HY
,
Sheppard W
&
Bernthal NM
. Delayed diagnosis is the primary cause of sarcoma litigation: analysis of malpractice claims in the United States. Clin Orthop Relat Res.
478(10)
2239
- 2253
2020.
DOI:
10.1097/CORR.0000000000001340
13
Gerrand C
,
Amary F
,
Anwar HA
,
Brennan B
,
Dileo P
,
Kalkat MS
,
McCabe MG
,
McCullough AL
,
Parry MC
,
Patel A
,
Seddon BM
,
Sherriff JM
,
Tirabosco R
&
Strauss SJ
. UK guidelines for the management of bone sarcomas. Br J Cancer.
132(1)
32
- 48
2025.
DOI:
10.1038/s41416-024-02868-4